Cardiovascular Diabetology

SEPTEMBER 15, 2024

Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. During the 4.22-year

Obesity 98

Obesity Heart Failure Diabetes Cardiomyopathy 98

Science Daily - Heart Disease

SEPTEMBER 13, 2024

Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother.

Diet 133

Diet Diabetes Cardiovascular Disease Obesity 133

Cardiology Update

JANUARY 24, 2024

The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

Science Daily - Heart Disease

NOVEMBER 18, 2024

This new insight into the flow of fats through the body points to new therapeutic targets for mitigating diseases like ASCVD, non-alcoholic fatty liver disease, obesity, diabetes, peripheral neuropathy, and neurodegeneration.

Cardiovascular Disease 87

Cardiovascular Disease Cholesterol Obesity Diabetes 87

Cardiometabolic Health Congress

FEBRUARY 1, 2024

Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovascular disease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91 million globally.

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

Med Page Today

JUNE 24, 2024

(MedPage Today) -- Metabolic surgery became the first therapy associated with a reduction in incident cardiovascular disease and death among patients with obesity and obstructive sleep apnea (OSA), based on a retrospective cohort study. Such patients.

Obesity 81

Obesity Cardiovascular Disease 81

Cardiovascular Diabetology

SEPTEMBER 11, 2024

Cardiovascular disease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.

Obesity 130

Obesity Risk Factors Cardiovascular Disease Diabetes 130

Dr. Paddy Barrett

FEBRUARY 21, 2025

For over 50 years, rates of those who are overweight or obese have been rising rapidly. Despite the rise in obesity rates, the growing recognition of it as a global problem and the astronomical sums of money we spend on addressing it, the tide continues to rise. That is until now.

Obesity 77

Obesity Diabetes Cardiovascular Disease Chronic Disease 77

Cardiovascular Diabetology

JUNE 5, 2024

Cardiovascular disease (CVD) is closely associated with the triglyceride glucose (TyG) index and its related indicators, particularly its combination with obesity indices. However, there is limited research on.

Cardiovascular Disease 59

Cardiovascular Disease Obesity Research 59

Cardiometabolic Health Congress

JANUARY 3, 2024

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Medical Xpress - Cardiology

JANUARY 17, 2024

is caused by cardiovascular disease, according to the U.S. Centers for Disease Control and Prevention. A robust body of evidence shows aerobic exercise can reduce risks, especially for people who are overweight or obese. Approximately one in three deaths in the U.S.

Cardiovascular Disease 80

Cardiovascular Disease Research Obesity Exercise 80

Science Daily - Heart Disease

SEPTEMBER 23, 2024

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.

Medicare 128

Medicare Obesity Cardiovascular Disease Diabetes 128

Med Page Today

MARCH 8, 2024

(MedPage Today) -- The FDA approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight, the agency announced on Friday. A GLP-1 receptor.

Heart Disease 141

Heart Disease Heart Attack Heart attacks Obesity 141

American College of Cardiology

SEPTEMBER 11, 2024

The following are key points to remember from a European Society of Cardiology (ESC) clinical consensus statement on obesity and cardiovascular disease (CVD).

Obesity 70

Obesity Cardiovascular Disease Article 70

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Despite its known correlations with risk of cardiovascular disease, awareness and testing for Lipoprotein (a) lags that of other serological markers with estimates that less than 1% of the US population have undergone screening.

Cardiovascular Disease 52

Cardiovascular Disease Biomarkers Obesity Outcomes 52

Circulation

MAY 20, 2024

Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Circulation, Ahead of Print.

Obesity 78

Obesity Public Health Research Cardiovascular Disease 78

Cardiometabolic Health Congress

JANUARY 15, 2025

Atherosclerosisa key driver of cardiovascular disease (CVD)continues to be a significant global health issue. The Global Burden of Disease data (2023) highlights a grim reality: while high-income countries have seen some success in managing CVD, LMICs now account for most CVD-related deaths.

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Journal of the American Heart Association

FEBRUARY 14, 2024

Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.

Cardiovascular Disease 73

Cardiovascular Disease Dementia Obesity Risk Factors 73

American College of Cardiology

JANUARY 8, 2024

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 71

Obesity Atrial Fibrillation Heart Failure Risk Factors 71

Cardiometabolic Health Congress

JANUARY 16, 2025

Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. School-Based Interventions: Creating Healthy Habits Early Programs that limit sugar-sweetened beverages and increase physical education very likely reduce childhood obesity.

Atherosclerosis 59

Atherosclerosis Risk Factors Coronary Artery Disease Cardiovascular Disease 59

Med Page Today

NOVEMBER 26, 2024

(MedPage Today) -- Men at high risk of cardiovascular disease had brain volume changes a decade earlier than women, U.K. Cardiovascular risk and obesity had the strongest relationship with lower gray matter volume in men between. Biobank data showed.

Obesity 110

Obesity Cardiovascular Disease 110

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

As a continuous variable, WWI was linked to higher rates of mortality from all-cause (HR=1.23, 95% CI=1.14, 1.33) and cardiovascular disease (CVD) (HR=1.43, 95% CI=1.23, 1.66) with hypertension in Model 3 adjusted for variables.

Hypertension 52

Hypertension Obesity Cardiovascular Disease Research 52

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. and Susan F. to 61% of the U.S.

Heart Disease 105

Heart Disease Blood Pressure Strokes Stroke 105

Circulation

JUNE 4, 2024

We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 26.8%) and obesity (43.1% Prevalences of coronary disease (7.8% in 2020 to 61.0% Diabetes (16.3%

Risk Factors 81

Risk Factors Cardiovascular Disease Strokes Stroke 81

Medical Xpress - Cardiology

APRIL 2, 2024

Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease.

Heart Disease 104

Heart Disease Obesity Cardiovascular Disease Diabetes 104

The New England Journal of Medicine

NOVEMBER 10, 2023

Overweight and obesity have reached epidemic proportions, affecting more than 70% of the U.S. 1 In addition to numerous health consequences, obesity contributes to cardiovascular disease indirectly through the development of risk factors and directly through various biologic mechanisms.2

Obesity 40

Obesity Cardiovascular Disease Risk Factors 40

American College of Cardiology

JANUARY 21, 2025

Overweight and obesity are common in patients with heterozygous familial hypercholesterolemia (HeFH) and are associated with a greater risk of atherosclerotic cardiovascular disease (ASCVD) starting in childhood and regardless of LDL-C level and lipid-lowering medication, according to a cross-sectional analysis published Jan.

Obesity 58

Obesity Cardiovascular Disease Article 58

Frontiers in Cardiovascular Medicine

APRIL 23, 2024

Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for over one-third of all deaths in Singapore. Furthermore, other major risk factors, such as diabetes mellitus, hypertension, elevated low-density lipoprotein levels, and obesity, are steadily rising. billion USD (11.5 billion SGD).

Cardiovascular Disease 52

Cardiovascular Disease Risk Factors Article Obesity 52

Frontiers in Cardiovascular Medicine

JANUARY 22, 2024

Introduction Cardiovascular diseases (CVDs) are the most important cause of premature death and disability worldwide. The etiological risk factors of CVDs are widely known and include dyslipidemia, obesity, diabetes, and chronic cigarette consumption.

Cardiovascular Disease 64

Cardiovascular Disease Risk Factors Physiology Obesity 64

Heart BMJ

SEPTEMBER 16, 2024

Obesity is a major global health issue and a leading cause of premature death. The prevalence of obesity has been rising faster than most other known modifiable risk factors. In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013.

Obesity 52

Obesity Blood Pressure BMI Risk Factors 52

Medical Xpress - Cardiology

JULY 9, 2024

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.

Obesity 52

Obesity Cardiovascular Disease Diabetes 52

Cardiovascular Diabetology

JANUARY 23, 2025

Obesity, a major risk factor for cardiovascular disease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.

Obesity 52

Obesity Risk Factors Cardiovascular Disease Hypertension 52

Cardiovascular Diabetology

NOVEMBER 26, 2024

Globally, cardiovascular disease (CVD) constitutes the primary cause of death, with insulin resistance (IR), measured by the triglyceride-glucose (TyG) index, and visceral obesity, reflected by the Chinese Vis.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2023

years; p  < 0.001), had more cardiovascular risk factors, target organ damage and cardiovascular disease (CVD) in comparison with those without hypertension. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 Conclusions About half of patients attended in primary care settings have hypertension in Spain.

Blood Pressure 134

Blood Pressure Hypertension Obesity Risk Factors 134

Cardiovascular Diabetology

JULY 10, 2024

The triglyceride-glucose (TyG) index and its combination with obesity indicators can predict cardiovascular diseases (CVD). However, there is limited research on the relationship between changes in the triglyc.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52

Cardiovascular Diabetology

MAY 28, 2024

Triglyceride and glucose (TyG) index, a surrogate marker of insulin resistance, has been validated as a predictor of cardiovascular disease. However, effects of TyG-related indices combined with obesity marker.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52